DIEPENBEEK, Belgium--(BUSINESS WIRE)---- $IPA #AI--Diepe IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA) (TSXV: IPA) is pleased to share that IPA’s subsidiary Biostrand, a Belgian end-to-end multi-omics analysis platform provider, has received a €460,000 round of grant funding from VLAIO (Flanders Innovation & Entrepreneurship), the research fund of the Flemish regional government in Belgium. Conditionally awarded in January this year, BioStrand recently satisfied the remainin
Full ArticleIPA’s Subsidiary BioStrand Secures Second VLAIO Research Grant
Business Wire
0 shares
1 views